The D299G/T399I toll-like receptor 4 variant associates with body and liver fat: Results from the TULIP and METSIM studies

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Weyrich, Peter ^a   Staiger, Harald ^a   Stančáková, Alena ^b   Machicao, Fausto ^a   Machann, Jü Rgen ^a   Schick, Fritz ^a   Stefan, Norbert ^a   Kuusisto, Johanna ^b   Laakso, Markku ^b   Schäfer, Silke ^a   Fritsche, Andreas ^a   Häring, Hans Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4;

ADIPOSE TISSUE; ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FINLAND; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOSITY; HUMAN; HYPERINSULINISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID COMPOSITION; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; GENE FREQUENCY; GENETICS; GERMANY; LIVER; METABOLISM; MIDDLE AGED;

ADIPOSE TISSUE; ADULT; AGED; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; BODY FAT DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; GENE FREQUENCY; GENOTYPE; GERMANY; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4;

EID: 78649750164     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013980     Document Type: Article

References (49)

1. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17: 4-12.
2. Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414: 782-787.
3. Fessler MB, Rudel LL., Brown JM. (2009) Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol.
4. Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145.
5. Gay NJ, Gangloff M (2007) Structure and function of Toll receptors and their ligands. Annu Rev Biochem 76: 141-165.
6. O'Neill LA (2008) The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 226: 10-18.
7. Krishnan J, Selvarajoo K, Tsuchiya M, Lee G, Choi S (2007) Toll-like receptor signal transduction. Exp Mol Med 39: 421-438.
8. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700.
9. Lee JY, Sohn KH, Rhee SH, Hwang D (2001) Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276: 16683-16689.
10. Song MJ, Kim KH, Yoon JM, Kim JB (2006) Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346: 739-745.
11. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025.
12. Radin MS, Sinha S, Bhatt BA, Dedousis N, O'Doherty RM (2008) Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 51: 336-346.
13. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, et al. (2007) Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acidinduced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27: 84-91.
14. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, et al. (2007) Loss-of-function mutation in Toll-like receptor 4 prevents dietinduced obesity and insulin resistance. Diabetes 56: 1986-1998.
15. Poggi M, Bastelica D, Gual P, Iglesias MA, Gremeaux T, et al. (2007) C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a highfat diet. Diabetologia 50: 1267-1276.
16. Wong SW, Kwon MJ, Choi AM, Kim HP, Nakahira K, et al. (2009) Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a ros-dependent manner. J Biol Chem.
17. Reyna SM, Ghosh S, Tantiwong P, Meka CS, Eagan P, et al. (2008) Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57: 2595-2602.
18. de Mello VD, Kolehmainen M, Pulkkinen L, Schwab U, Mager U, et al. (2008) Downregulation of genes involved in NFkappaB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study. Diabetologia 51: 2060-2067.
19. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al. (2001) DbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
20. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al (2003) The International HapMap Project. Nature 426: 789-796.
21. Ferwerda B, McCall MB, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, et al. (2007) TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A 104: 16645-16650.
22. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, et al. (2008) Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 14: 346-352.
23. Awomoyi AA, Rallabhandi P, Pollin TI, Lorenz E, Sztein MB, et al. (2007) Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 179: 3171-3177.
24. Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A, et al. (2008) Tolllike receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 359: 1766-1777.
25. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191.
26. Smirnova I, Mann N, Dols A, Derkx HH, Hibberd ML, et al. (2003) Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci U S A 100: 6075-6080.
27. van der Graaf C, Kullberg BJ, Joosten L, Verver-Jansen T, Jacobs L, et al. (2005) Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine 30: 264-268.
28. Feterowski C, Emmanuilidis K, Miethke T, Gerauer K, Rump M, et al. (2003) Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 109: 426-431.
29. Illig T, Bongardt F, Schopfer A, Holle R, Muller S, et al. (2003) The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 52: 2861-2864.
30. Kolz M, Baumert J, Muller M, Khuseyinova N, Klopp N, et al. (2008) Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol. BMC Med Genet 9: 9.
31. Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, Ksiazek A (2009) Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Hum Immunol 70: 121-124.
32. Rudofsky G, Jr., Reismann P, Witte S, Humpert PM, Isermann B, et al. (2004) Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes. Diabetes Care 27: 179-183.
33. Bagarolli RA, Saad MJ, Saad ST (2009) Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with Type 2 diabetes. J Diabetes Complications.
34. Steinhardt AP, Aranguren F, Tellechea ML, Gomez Rosso LA, Brites FD, et al. (2010) A functional nonsynonymous toll-like receptor 4 gene polymorphism is associated with metabolic syndrome, surrogates of insulin resistance, and syndromes of lipid accumulation. Metabolism 59: 711-717.
35. Schafer S, Kantartzis K, Machann J, Venter C, Niess A, et al. (2007) Lifestyle intervention in individuals with normal versus impaired glucose tolerance. European Journal of Clinical Investigation 37: 535-543.
36. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
37. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062.
38. Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, et al. (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21: 455-462.
39. Stefan N, Machicao F, Staiger H, Machann J, Schick F, et al. (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48: 2282-2291.
40. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
41. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
42. Weyrich P, Machicao F, Staiger H, Simon P, Thamer C, et al. (2007) Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites. Diabetologia 50: 2097-2106.
43. Stefan N, Kantartzis K, Haring HU (2008) Causes and metabolic consequencesof Fatty liver. Endocr Rev 29: 939-960.
44. MacLaren R, Cui W, Cianflone K (2008) Adipokines and the immune system: an adipocentric view. Adv Exp Med Biol 632: 1-21.
45. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280: E745-751.
46. Zha JM, Di WJ, Zhu T, Xie Y, Yu J, et al. (2009) Comparison of Gene Transcription between Subcutaneous and Visceral Adipose Tissue in Chinese Adults. Endocr J.
47. Zhang HM, Chen LL, Wang L, Xu S, Wang X, et al. (2009) Macrophage infiltrates with high levels of Toll-like receptor 4 expression in white adipose tissues of male Chinese. Nutr Metab Cardiovasc Dis.
48. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87: 3023-3028.
49. Thamer C, Machann J, Stefan N, Haap M, Schafer S, et al. (2007) High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity (Silver Spring) 15: 531-538.